This is the last article you can read this month
You can read more article this month
You can read more articles this month
Sorry your limit is up for this month
A SALIVA test designed to diagnose concussion is set to be trialled in the Premier League, it was reported today.
A joint action plan on brain health published by the league, along with the Football Association, the EFL and the Professional Footballers’ Association, sets out details of work being done to protect current footballers from concussion and sub-concussive impacts, and to understand why there is an increased risk of neurodegenerative disease among professional footballers compared to the general population.
It confirms the Premier League is funding an academic study to validate a diagnostic tool which uses salivary biomarkers, and it is understood the trial could begin later this season.
Players will provide baseline swabs, then at three further time points following a concussive injury, the plan said. Comparative swabs will be taken from an uninjured player and another player who has suffered a musculoskeletal injury in the same match or training session.
The plan stated: “The first phase of this research will be carried out over a three-year period, with interim and final results reviewed jointly by the football stakeholders to inform future concussion protocols.”
It follows the publication of the SCRUM study findings in March, which showed a saliva biomarker tool was able to accurately detect concussion in elite male rugby players.
That study, led by academics at the University of Birmingham, successfully predicted the outcome of head injury assessments (HIAs) in 94 per cent of cases during testing in the 2018-19 Premiership and Championship season.
Researchers from Birmingham said at the time of the study’s publication that the technology behind rapid coronavirus testing could be harnessed to enable biomarker tests to be conducted in-game and provide an objective diagnosis of concussion, alongside existing assessment techniques.
The 2019 FIELD Study, led by academics at Glasgow University, concluded footballers were three-and-a-half times more likely to die of neurodegenerative disease than age-matched members of the general population, leading to an increased focus on the management of concussion and the sub-concussive impact of repeated heading in the game.
The FA’s BrainHOPE study, which starts next year, will also be conducted by Glasgow University, and will analyse the deterioration of cognitive function in former players to understand potential early interventions which could help reduce the risk or speed of developing dementia. The study, which has received £1.2million of funding, will run until the 2024-25 season.
The FA is also partnering with the Rugby Football Union and Premiership Rugby to expand the Advanced BRAIN Health Clinic to include retired footballers in 2022.
It will give the ex-players access to specialist clinical services in a bid to proactively manage their brain health after retirement.
Current and former footballers, along with their families, are being consulted over the action plan, with their feedback helping to shape an updated version which will be published before the start of next season.
You can’t buy a revolution, but you can help the only daily paper in Britain that’s fighting for one by joining the 501 club.
Just £5 a month gives you the opportunity to win one of 17 prizes, from £25 to the £501 jackpot.
By becoming a 501 Club member you are helping the Morning Star cover its printing, distribution and staff costs — help keep our paper thriving by joining!
You can’t buy a revolution, but you can help the only daily paper in Britain that’s fighting for one by become a member of the People’s Printing Press Society.
The Morning Star is a readers’ co-operative, which means you can become an owner of the paper too by buying shares in the society.
Shares are £1 each — though unlike capitalist firms, each shareholder has an equal say. Money from shares contributes directly to keep our paper thriving.
Some union branches have taken out shares of over £500 and individuals over £100.
You can’t buy a revolution, but you can help the only daily paper in Britain that’s fighting for one by donating to the Fighting Fund.
The Morning Star is unique, as a lone socialist voice in a sea of corporate media. We offer a platform for those who would otherwise never be listened to, coverage of stories that would otherwise be buried.
The rich don’t like us, and they don’t advertise with us, so we rely on you, our readers and friends. With a regular donation to our monthly Fighting Fund, we can continue to thumb our noses at the fat cats and tell truth to power.
Donate today and make a regular contribution.